Breast Implant Illness: What's Known So Far
SaveBreast implant illness (BII) describes a cluster of symptoms - fatigue, joint pain, brain fog - that some people link to their implants. It is not an established diagnosis, and studies have not proven implants cause it, though regulators acknowledge the reports. A separate, rare cancer called BIA-ALCL is linked mainly to textured implants.
Last updated: July 2026
What is breast implant illness?
Breast implant illness is a patient-named term, not a formal diagnosis, for a broad set of symptoms attributed to breast implants. Commonly reported symptoms include fatigue, joint and muscle pain, brain fog, hair loss, rashes, and dry eyes. Because these symptoms are common in the general population and overlap with conditions like thyroid disease and autoimmune disorders, they are difficult to tie to implants specifically.
No laboratory test confirms BII, and the medical community has not agreed on diagnostic criteria. Regulators describe the reports as real experiences that warrant attention while noting that a causal link has not been proven. Understanding that uncertainty is the honest starting point.
Is breast implant illness real, and what does the evidence say?
The honest answer is that the evidence is incomplete and evolving. Large studies have not demonstrated that implants cause a distinct illness, yet many people report meaningful symptom improvement after implants are removed, which keeps the question open. Some of that improvement may reflect the natural course of symptoms, the effect of surgery, or expectation.
What is well established is that breast-cancer screening still matters for anyone with implants, since implants can obscure part of the breast on a mammogram and extra views are often used. According to the National Cancer Institute, regular screening lowers breast-cancer deaths by roughly 20% and is recommended for average-risk women beginning in their 40s and repeated every 1 to 2 years; that is when regular mammograms begin for most women 1Ref 1National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Breast Cancer Screening.Regular screening mammography lowers breast-cancer mortality and is recommended for average-risk women beginning in their 40s every 1 to 2 years; implants and dense tissue can obscure findings, so technique matters.. About 40 in 100 women have dense breast tissue that can also hide findings, so imaging technique matters.
What is BIA-ALCL, and how is it different?
BIA-ALCL is a separate and well-defined condition, unlike the contested BII. Its full name is breast implant-associated anaplastic large cell lymphoma, a rare cancer of the immune system that develops in the scar-tissue capsule around an implant. Regulators and cancer bodies recognize it and link it mainly to textured-surface implants rather than smooth ones.
Warning signs include new swelling, fluid collection, or a lump around an implant, often years after placement. Because it is a defined cancer, BIA-ALCL has clear evaluation and treatment pathways, and most cases are treatable when caught early. A new breast lump near an implant is a reason to be evaluated promptly, which is different from the symptom-based, unproven picture of BII.
How should you evaluate symptoms you think are from implants?
A structured evaluation helps separate implant-related symptoms from other causes. A clinician can review your symptom timeline over the past 3 to 6 months, examine the implants, and test for common, treatable explanations such as thyroid disease, anemia, autoimmune conditions, and vitamin deficiencies. Keeping age-appropriate breast screening current is part of that work-up.
The American College of Obstetricians and Gynecologists recommends screening mammography as a core service for average-risk women, generally every 1 to 2 years 2Ref 2American College of Obstetricians and Gynecologists (2017).Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.Screening mammography is a core service for average-risk women, typically repeated every 1 to 2 years, regardless of implant status., and a well-woman visit is a practical setting to raise implant symptoms 3Ref 3American College of Obstetricians and Gynecologists (2018).ACOG Committee Opinion No. 755: Well-Woman Visit.The well-woman visit is a practical setting to raise breast symptoms and confirm that screening is up to date.. Imaging such as ultrasound or MRI can assess an implant for rupture or fluid. If symptoms persist and other causes are excluded, some people consider explant with a plastic surgeon. Checking what breast changes warrant concern helps you report the right details.
When implant symptoms need a specialist
Implant-related concerns often cross several specialties, so knowing whom to see matters. A plastic surgeon evaluates the implants themselves, discusses explant, and manages any BIA-ALCL concern, while a primary-care or women's-health clinician investigates treatable causes and keeps screening on track. Symptoms and risks also shift across life stages.
Implants placed after pregnancy, for reconstruction, or in the perimenopausal years each carry different questions, and symptoms that overlap with perimenopause or thyroid changes deserve a broad work-up rather than a single explanation. Keeping screenings across the decades current supports that. A rapidly enlarging, swollen, or painful implant is a reason to seek prompt evaluation. Gale can help you organize your symptom history and screening records for those conversations, though implant surgery itself is outside our scope.
Common questions
Related
Breast health
Mammograms With Implants: Extra Views, Same GoalBreast health
Intraductal Papilloma: A Benign Discharge CauseBreast health
Fibroadenoma: The Most Common Benign Lump
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
Implant symptoms that need prompt evaluation
- —New swelling, fluid collection, or enlargement of one breast around an implant is a reason to seek prompt clinician evaluation, as it can signal BIA-ALCL.
- —A new lump or hard area near an implant is a reason to arrange a diagnostic assessment with a clinician.
- —Redness, warmth, and swelling that come on quickly are a reason to contact a clinician promptly, as they can indicate infection.
- —Persistent, worsening symptoms that limit daily life are a reason to seek a clinician review to look for treatable causes.
This article is general health education about breast implant illness and BIA-ALCL, not medical advice. Decisions about implants, explant, or a symptom work-up are made with a plastic surgeon and your primary care or women's health clinician.
References
- 1.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Breast Cancer Screening. National Cancer Institute (NCI), NIH. link ✓Regular screening mammography lowers breast-cancer mortality and is recommended for average-risk women beginning in their 40s every 1 to 2 years; implants and dense tissue can obscure findings, so technique matters.
- 2.American College of Obstetricians and Gynecologists (2017). Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002158 ✓Screening mammography is a core service for average-risk women, typically repeated every 1 to 2 years, regardless of implant status.
- 3.American College of Obstetricians and Gynecologists (2018). ACOG Committee Opinion No. 755: Well-Woman Visit. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002897 ✓The well-woman visit is a practical setting to raise breast symptoms and confirm that screening is up to date.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy